GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $49,000 | +88.5% | 1,134 | +89.0% | 0.04% | +118.8% |
Q1 2022 | $26,000 | 0.0% | 600 | 0.0% | 0.02% | 0.0% |
Q4 2021 | $26,000 | +13.0% | 600 | 0.0% | 0.02% | +6.7% |
Q3 2021 | $23,000 | -4.2% | 600 | 0.0% | 0.02% | -6.2% |
Q2 2021 | $24,000 | +14.3% | 600 | 0.0% | 0.02% | +6.7% |
Q1 2021 | $21,000 | -4.5% | 600 | 0.0% | 0.02% | -6.2% |
Q4 2020 | $22,000 | -33.3% | 600 | -30.6% | 0.02% | -40.7% |
Q3 2020 | $33,000 | -5.7% | 864 | 0.0% | 0.03% | -12.9% |
Q2 2020 | $35,000 | +6.1% | 864 | 0.0% | 0.03% | 0.0% |
Q1 2020 | $33,000 | +175.0% | 864 | +227.3% | 0.03% | +181.8% |
Q4 2019 | $12,000 | – | 264 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |